SG11201610062YA - Ophthalmic composition for the treatment of ocular infection - Google Patents

Ophthalmic composition for the treatment of ocular infection

Info

Publication number
SG11201610062YA
SG11201610062YA SG11201610062YA SG11201610062YA SG11201610062YA SG 11201610062Y A SG11201610062Y A SG 11201610062YA SG 11201610062Y A SG11201610062Y A SG 11201610062YA SG 11201610062Y A SG11201610062Y A SG 11201610062YA SG 11201610062Y A SG11201610062Y A SG 11201610062YA
Authority
SG
Singapore
Prior art keywords
treatment
ophthalmic composition
ocular infection
ocular
infection
Prior art date
Application number
SG11201610062YA
Other languages
English (en)
Inventor
Erwin C Si
Original Assignee
Coopervision Int Holding Co Lp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coopervision Int Holding Co Lp filed Critical Coopervision Int Holding Co Lp
Publication of SG11201610062YA publication Critical patent/SG11201610062YA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • A61K9/0051Ocular inserts, ocular implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201610062YA 2014-06-20 2015-06-18 Ophthalmic composition for the treatment of ocular infection SG11201610062YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462014777P 2014-06-20 2014-06-20
PCT/GB2015/051790 WO2015193677A1 (en) 2014-06-20 2015-06-18 Ophthalmic composition for the treatment of ocular infection

Publications (1)

Publication Number Publication Date
SG11201610062YA true SG11201610062YA (en) 2016-12-29

Family

ID=53539736

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201610062YA SG11201610062YA (en) 2014-06-20 2015-06-18 Ophthalmic composition for the treatment of ocular infection

Country Status (13)

Country Link
US (1) US9789058B2 (es)
EP (1) EP3157507B1 (es)
JP (1) JP6200108B2 (es)
KR (1) KR20170014006A (es)
CN (1) CN106456710A (es)
AU (1) AU2015275896B2 (es)
CA (1) CA2952772C (es)
GB (1) GB2541840B (es)
HU (1) HUE047107T2 (es)
MX (1) MX355853B (es)
MY (1) MY177504A (es)
SG (1) SG11201610062YA (es)
WO (1) WO2015193677A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2826550T3 (es) * 2015-06-15 2021-05-18 Braun Melsungen Ag Agentes activos antimicrobianos y su uso
KR101962882B1 (ko) 2017-06-01 2019-03-28 한국과학기술연구원 구연산염 검출 센서 및 이를 이용한 구연산염 검출 방법
US11129862B2 (en) * 2017-08-30 2021-09-28 Johnson & Johnson Consumer Inc. Ophthalmic compositions
CN111202746B (zh) * 2020-02-27 2021-03-16 潍坊医学院附属医院 一种眼用复合制剂及其制备方法
CN111840225B (zh) * 2020-08-12 2021-09-14 陈丽娜 一种用于治疗青光眼的滴眼剂及其制备方法
TWI815436B (zh) * 2022-05-10 2023-09-11 長庚大學 使用聚離胺酸奈米粒子來治療乾眼症

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4730013A (en) 1981-10-08 1988-03-08 Merck & Co., Inc. Biosoluble ocular insert
US6187264B1 (en) 1996-02-02 2001-02-13 Asahi Kasei Kogyo Kabushiki Kaisha Solution for preserving and sterilizing contact lenses
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
JP2001261552A (ja) 2000-03-22 2001-09-26 Chisso Corp 点眼液用保存剤
JP2002020320A (ja) * 2000-06-30 2002-01-23 Santen Pharmaceut Co Ltd 点眼液用防腐剤
JP4255839B2 (ja) * 2002-02-07 2009-04-15 株式会社オフテクス コンタクトレンズ用液剤
ATE422894T1 (de) * 2002-03-21 2009-03-15 Cayman Chem Co Prostaglandin f2 alpha analoga in kombination mit einem antimikrobiellen mittel zur behandlung von glaukom
JP2006201247A (ja) 2005-01-18 2006-08-03 Taki Chem Co Ltd コンタクトレンズ用消毒保存溶液
CN101822736A (zh) * 2010-03-08 2010-09-08 深圳市倍安蒂科技有限公司 一种新型生物杀菌剂及其制备方法
JP2011245053A (ja) * 2010-05-27 2011-12-08 Nanyang Technological Univ 眼用及び医療用の重合性組成物及びそれを重合して得られる抗菌性組成物
US20130156791A1 (en) * 2010-08-09 2013-06-20 Jean-luc Perfettini Methods and pharmaceutical compositions for the treatment of hiv-1 infections
CN101954113B (zh) 2010-08-13 2014-03-19 北京赛奇科科技有限公司 可防止眼外科手术后感染和渗漏的凝胶涂敷套件
EP2666484B1 (en) * 2011-01-19 2016-11-30 Menicon Co., Ltd. Liquid preparation for contact lenses
US20120215184A1 (en) 2011-02-18 2012-08-23 Valeant International (Barbados) Srl Cylindrical ocular inserts
US20120277239A1 (en) * 2011-04-28 2012-11-01 Alpha Synergy Development Inc. Compositions and Methods for Improving Night Vision
US20140178327A1 (en) * 2012-12-21 2014-06-26 Coopervision International Holding Company, Lp Antimicrobial Ophthalmic Devices
JP6260042B2 (ja) 2013-05-27 2018-01-17 学校法人玉川学園 抗アカントアメーバ用組成物及び該抗アカントアメーバ用組成物を含有する眼科用剤

Also Published As

Publication number Publication date
GB2541840B (en) 2017-09-06
EP3157507A1 (en) 2017-04-26
US9789058B2 (en) 2017-10-17
US20170196805A1 (en) 2017-07-13
JP6200108B2 (ja) 2017-09-20
GB2541840A (en) 2017-03-01
MX2016016090A (es) 2017-07-13
KR20170014006A (ko) 2017-02-07
CA2952772A1 (en) 2015-12-23
WO2015193677A1 (en) 2015-12-23
CN106456710A (zh) 2017-02-22
AU2015275896B2 (en) 2017-05-18
EP3157507B1 (en) 2019-07-31
AU2015275896A1 (en) 2017-01-12
HUE047107T2 (hu) 2020-04-28
JP2017518332A (ja) 2017-07-06
CA2952772C (en) 2018-06-12
GB201621904D0 (en) 2017-02-01
MX355853B (es) 2018-05-02
MY177504A (en) 2020-09-17

Similar Documents

Publication Publication Date Title
IL283561B (en) Methods for treating eye diseases
HRP20190117T1 (hr) iRNK TERAPIJA ZA LIJEČENJE BOLESTI OKA
EP3177732A4 (en) Compositions and methods for the treatment of ophthalmic diseases and conditions
IL246791A0 (en) Compositions and methods for treating eye diseases
HK1256721A1 (zh) 用於治療眼部病症的化合物和組合物
EP3374502A4 (en) METHOD FOR THE TREATMENT OF CORNEAL DYSTROPHIES
IL272601A (en) Pharmaceutical preparations for the treatment of ophthalmic conditions
GB2541840B (en) Ophthalmic composition for the treatment of ocular infection
RS61504B1 (sr) Jedinjenja heteroarila za lečenje oftalmičkih bolesti
IL249502A0 (en) Novel therapeutic uses of benzylideneguanidine derivatives for the treatment of protein-associated diseases
EP3324890A4 (en) GLACO-TREATMENT VIA INTRAKAMERAL EYE IMPLANTS
EP3089748A4 (en) Treating ocular neovascularization
EP3099304A4 (en) Novel therapeutics for the treatment of glaucoma
EP3213762A4 (en) Novel treatment of cornea using laminin
EP3209295A4 (en) Methods of treating ocular conditions
EP3474836C0 (en) OPHTHALMIC MEDICINE CONTAINING SALBUTAMOL.
EP3302382A4 (en) IMPLANT FOR THE TREATMENT OF OCULAR DISEASE
IL259381B (en) Miravegron for the treatment of retinal diseases
PT3407879T (pt) Gabapentina oftálmica para o tratamento de úlceras da córnea
PL3229780T3 (pl) Kompozycje okulistyczne do zastosowania w leczeniu zespołu suchego oka
PL3302463T3 (pl) Zastosowanie 3 deoksyantocyjanidyn w leczeniu chorób oczu
EP3148538A4 (en) Cenicriviroc for the treatment of hiv-2 infection
IL263837A (en) Treatment of ocular disease
GB201610938D0 (en) Treatment of ocular disease
GB201406623D0 (en) Treatment of optical aberration/s